about
Laparoscopy versus laparotomy for FIGO stage I ovarian cancerLaparoscopy versus laparotomy for FIGO Stage I ovarian cancerIntraperitoneal administration of telomerase-specific oncolytic adenovirus sensitizes ovarian cancer cells to cisplatin and affects survival in a xenograft model with peritoneal dissemination.MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a.MicroRNA-223-3p Regulates Ovarian Cancer Cell Proliferation and Invasion by Targeting SOX11 Expression.Vaginal rupture caused by transvaginal ultrasonography in follow-up for ovarian cancer.Laparoscopy versus laparotomy for FIGO stage I ovarian cancer.Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter?Safety and efficacy of video laparoscopic surgical debulking of recurrent ovarian, fallopian tube, and primary peritoneal cancers.MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer.MicroRNA-215 targets NOB1 and inhibits growth and invasion of epithelial ovarian cancer.MiR-381 inhibits epithelial ovarian cancer malignancy via YY1 suppression.The role of HE4 for prediction of recurrence in epithelial ovarian cancer patients-results from the OVCAD study.MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1.miR-144 Potentially Suppresses Proliferation and Migration of Ovarian Cancer Cells by Targeting RUNX1.Value of tertiary cytoreductive surgery in epithelial ovarian cancer: an international multicenter evaluation.Impact of obesity on operative morbidity and clinical outcome in primary epithelial ovarian cancer after optimal primary tumor debulking.
P2860
Q24200857-EE981B0A-95B6-4534-9B48-7B16518677B0Q24241345-58E06D67-3557-40BE-B5D7-CEF0588A91D3Q33710438-902214F6-F745-4CD5-AB84-DEE184FF3A09Q33733010-D074AFA7-E0C9-4990-ACC0-D4F6B4FDA579Q33838718-204EA2DA-BC32-4E67-A46F-506044C5E5EFQ34524364-B208FD0A-4BD3-48A8-8B14-5F9FACEAD46BQ34542548-E792DF0A-A85A-4BC6-AD30-E8A1C05EFE6FQ36557877-03E363D5-76F4-481F-AC45-D7A918B68C53Q36573447-148D99A4-94F5-402D-83BF-8EA138AE600AQ37060790-7D415D5E-DFEA-431C-BC35-CE192B3AEEF3Q37685240-E62A3B7D-220C-4575-A63B-E0DB37AEDB3CQ38803584-B2624241-B43E-452F-BF9C-44360AC1D1C9Q40485803-FD132173-2D3B-4771-8CFD-C5A095E2FAF0Q47157421-D1AB4C56-19FE-49E7-8FAD-53E3BDDF2DE5Q50353125-E7B01A73-3B86-4247-B198-DAF35621A4B3Q52886435-B6D1A06E-84D7-4671-80BB-36C594CE2BA0Q52897352-E1F61411-5CD1-42EA-B846-6E35AE9F00E4
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Surgical standards in the management of ovarian cancer.
@ast
Surgical standards in the management of ovarian cancer.
@en
Surgical standards in the management of ovarian cancer.
@nl
type
label
Surgical standards in the management of ovarian cancer.
@ast
Surgical standards in the management of ovarian cancer.
@en
Surgical standards in the management of ovarian cancer.
@nl
prefLabel
Surgical standards in the management of ovarian cancer.
@ast
Surgical standards in the management of ovarian cancer.
@en
Surgical standards in the management of ovarian cancer.
@nl
P1476
Surgical standards in the management of ovarian cancer.
@en
P2093
Bristow RE
P304
P356
10.1097/00001622-200009000-00015
P577
2000-09-01T00:00:00Z